Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT01193244 · COMPLETED

Trial details

NCT number: NCT01193244
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-10-01
Primary completion: 2014-01-01
Enrollment: 1560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.